Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
04/2008
04/09/2008EP1908764A1 Azolo triazines and pyrimidines
04/09/2008EP1907393A2 Introverted cucurbituril compounds
04/09/2008EP1907392A1 Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase
04/09/2008EP1907388A1 Novel heteroaryl fused cyclic amines
04/09/2008EP1906965A2 Azaindazole compounds and methods of use
04/09/2008EP1906964A1 Piperazinone derivatives useful as histamine h3 receptor antagonists and/or inverse agonists
04/09/2008EP1309565B1 Heterocyclic mutilin esters and their use as antibacterials
04/09/2008CN101160314A Small molecule inhibitors of mdm2 and the uses thereof
04/09/2008CN101160313A Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents
04/09/2008CN101160312A Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents
04/09/2008CN101160311A Polymorphic form of 6- (4-chlorophenyl) -2, 2-dimethyl-7-phenyl-2, 3-dihydro-lh-pyrrolizin-5-ylacetic acid
04/09/2008CN101160308A Methods of treating cancer and related methods
04/09/2008CN101160125A Niacin receptor agonists, compositions containing such compounds and methods of treatment
04/09/2008CN101160049A Spiroketal-substituted cyclic ketoenols
04/09/2008CN101157695A New purine alkaloid and preparation method and application thereof
04/09/2008CN101157591A Method for amido deoxidization from nitryl of compound containing nitryl phenyl
04/09/2008CN100379744C The use of anti-histaminics for acute reduction of elevated intracranial pressure
04/09/2008CN100379740C Water-soluble phthalocyanine compound-containing ink for ink jetting, ink jet recording method and method for improving ozone gas discoloration of colored image material
04/09/2008CN100379739C Process for preparing azacycloalkanoylaminothiazoles
04/09/2008CN100379734C Azaindoles
04/09/2008CN100379729C Nitro compounds and their application in preparation of pemetrexed
04/09/2008CN100379421C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
04/08/2008US7354946 Biarylurea derivatives
04/08/2008US7354937 (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane
04/08/2008US7354929 6-benzyl-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-2,6-dihydropyrazolo[3,4-c]pyridin-7-one; eating and psychological disorders; obesity, alcoholism
04/08/2008US7354924 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
04/08/2008US7354923 Piperazine melanocortin-specific compounds
04/08/2008US7354921 Pyrazolotriazines as kinase inhibitors
04/08/2008US7354905 Thrombosis therapy; anticoagulants
04/08/2008US7354771 Method of determining absolute configuration of chiral compound
04/03/2008WO2008039520A2 Fused ring compounds for inflammation and immune-related uses
04/03/2008WO2008039420A2 Novel inhibitors of beta-lactamase
04/03/2008WO2008039359A2 Bicyclic pyrimidine kinase inhibitors
04/03/2008WO2008039324A1 Transition state structure of human 5'-methylthioadenosine phosphorylase
04/03/2008WO2008038765A1 Optical information recording medium and azo metal complex dye
04/03/2008WO2008038679A1 Phthalocyanine compound and process for production thereof
04/03/2008WO2008038646A1 Process for production of 2,5-dioxopyrrolidine-3-carboxylate
04/03/2008WO2008038251A2 3-aza-bicyclo[3.1.0]hexane derivatives
04/03/2008WO2008038031A1 An improved process for the preparation of temozolomide and analogs
04/03/2008WO2008037881A2 Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof
04/03/2008WO2008037681A1 5-{2-[4-(2-methyl-5-quinolinyl)-l-piperidinyl] ethyl} quinolinone derivatives as 5ht1a receptor modulators for treating sexual dysfunction, cognition impairement, psychotic disorders, anxiety, depression, etc.
04/03/2008WO2008037607A1 Heterocyclic compounds containing carbonyl groups, and the use thereof for controlling phytopathogenic fungi
04/03/2008WO2008037477A1 Pyrazolopyrimidines as p13k lipid kinase inhibitors
04/03/2008WO2008037459A1 Pyrazolo [1, 5-a] pyrimidine derivatives and their therapeutic use
04/03/2008WO2008037011A1 Polycyclic agents for the treatment of respiratory syncytial virus infections
04/03/2008WO2008021545A3 Modulators of muscarinic receptors
04/03/2008WO2008017883A3 4-oxo-4,5-dihydropyrrolo[1,2-a] quinoxaline derivatives as inhibitors of poly(adp-ribose)polymerase(parp)
04/03/2008WO2008012622A3 Azabenzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
04/03/2008WO2007146375A3 Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer
04/03/2008WO2007139860A3 Heterobicylic metalloprotease inhibitors
04/03/2008WO2007139856A3 Heterobicyclic metalloprotease inhibitors
04/03/2008US20080081820 SUBSTITUTED 8'-PYRI(MI)DINYL-DIHYDROSPIRO-[CYCLOALKYLAMINE]-PYRIMIDO[1,2-a]PYRIMIDIN-6-ONE DERIVATIVES
04/03/2008US20080081819 1'-[(2S)-2-Hydroxy-2-phenylethyl]-8'-pyridin-4-yl-3',4'-dihydrospiro[cyclopropane-1,2'-pyrimido[1,2-a]pyrimidin]-6'(1'H)-one; glycogen synthase kinase-3 beta inhibitor; neurodegenerative disease, non-insulin dependent diabetes; inhibit amyloid precursor protein and tau protein hyperphosphorylation
04/03/2008US20080081817 7-(3-ethoxybenzyl)-4-[4-[[trans-4-[[N-(2-methoxyethyl)-N-(tert-butyl)amino]methyl]cyclohexyl]carbonyl]piperazin-1-yl]-7H-pyrrolo[2,3-d]pyrimidine; small-conductance calcium activated potassium channel (SK) blocking agent; gastrointestinal, central nervous system disorders, myotonic muscular dystrophy
04/03/2008US20080081807 Arylphenyl-substituted cyclic keto-enols
04/03/2008CA2847852A1 Inhibitors of bruton's tyrosine kinase
04/03/2008CA2664378A1 Pyrazolopyrimidines as pi3k lipid kinase inhibitors
04/03/2008CA2664376A1 Polycyclic agents for the treatment of respiratory syncytial virus infections
04/03/2008CA2664375A1 Pyrazolo [1, 5-a] pyrimidine derivatives and their therapeutic use
04/03/2008CA2664296A1 Novel inhibitors of beta-lactamase
04/03/2008CA2664052A1 An improved process for the preparation of temozolomide and analogs
04/03/2008CA2663562A1 Transition state structure of human 5'-methylthioadenosine phosphorylase
04/03/2008CA2663080A1 Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof
04/03/2008CA2662612A1 3-aza-bicyclo[3.1.0]hexane derivatives
04/02/2008EP1905774A1 Fused heterocyclic compounds as serotonin receptor modulators
04/02/2008EP1905773A2 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
04/02/2008EP1904504A2 Inhibitors of vegf receptor and hgf receptor signaling
04/02/2008EP1904500A1 New derivatives of heptaazaphenalene, methods for obtaining them, and their use as protecting agents against uv radiation
04/02/2008EP1904499A1 Process for the preparation of zopiclone
04/02/2008EP1904498A1 Fused heterocyclic derivatives and use thereof
04/02/2008EP1904497A1 Substituted rylene derivatives
04/02/2008EP1904496A2 Compositions and methods pertaining to pna synthons and oligomers comprising a universal base
04/02/2008EP1904461A2 Cyclic anilinopyridinotriazines as gsk-3 inhibitors
04/02/2008EP1904453A2 Synergistic composition and method for inhibiting growth of microorganisms
04/02/2008EP1697384B1 Pyrido- and pyrimidopyrimidine derivatives as anti-proliferative agents
04/02/2008EP1453506B1 Topoisomerase poison agents
04/02/2008CN101155785A Novel adenosine a3 receptor modulators
04/02/2008CN101153041A 1,2,3-triazole 1,3-nitrogen heterocyclic, producing method and application of the same
04/02/2008CN101153040A Method for synthesizing polyhydroxy pyrroline acridine alkaloid
04/02/2008CN100378103C Process for extracting protohemin by using surfactant
04/02/2008CN100378102C Process for preparation of phthalocyanin compound and intermediate and these intermediate compound
04/02/2008CN100378101C 1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives
04/02/2008CN100378100C Pyrazolo(4,3-d)pyrimidine derivatives
04/02/2008CN100378074C 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
04/01/2008US7351839 Process for the preparation of 1,2,3,4,8,9,10, 10a-octahydro-7bH-cyclopenta[b][1,4]diazepino-[6,7,1-hi]indole derivatives
04/01/2008US7351833 (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
04/01/2008US7351827 Substituted oxetanes, method of making, and method of use thereof
04/01/2008US7351826 Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compounds
04/01/2008US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
04/01/2008US7351732 Serotonin (5-hydroxytriptamine, 5-HT) 5-HT1A receptor subtype agonists; neuroprotective agents; cerebral damage due to traumatic or ischemic stroke; 2-[4-[(Chroman-2-yl)methylamine]butyl]-1,3-dioxoperhydropyrrolo[1,2-c]imidazol
04/01/2008US7351710 Solid N-Methyl-N-[3-[3-[2-thienylcarbonyl]pyrazolo[1,5-a]pyrimidin-7-yl]phenyl]acetamide; X-ray powder diffraction pattern lacks discernible or sharp peaks
04/01/2008US7351708 Pyrrolo [2,3-b] pyridine derivatives
04/01/2008US7351701 Therapeutic compounds
04/01/2008CA2432578C Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
03/2008
03/27/2008WO2008036759A1 Spiro benzazepines as vasopressin antagonists
03/27/2008WO2008036755A1 Spiro benzazepines used as vasopressin antagonists
03/27/2008WO2008036579A1 Thiazole pyrazolopyrimidines as crf1 receptor antagonists
03/27/2008WO2008036541A1 Thiophene pyrazolopyrimidine compounds
03/27/2008WO2008036277A1 Pyraz0l0(l,5-a) (1, 3, 5) triazine and pyrazolo (1, 5-a) pyrimidine derivatives useful as protein kinase inhibitors
03/27/2008WO2008034731A1 Octahydropyrrolo [3, 4-c] pyrrole derivatives an their use as antiviral agents